Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Annexon Biosciences (ANNX)
NASDAQ:ANNX
RESEARCH TOOLSreports
Holding ANNX?
Track your performance easily
Annexon Biosciences (ANNX) Ownership Overview
13.86% Insiders
16.25% Mutual Funds
0.51% Other Institutional Investors
24.51% ETFs
44.86% Public Companies and Individual Investors
The ownership structure of Annexon Biosciences (ANNX) stock is a mix of institutional, retail, and individual investors. Approximately 41.27% of the company’s stock is owned by Institutional Investors, 13.86% is owned by Insiders, and 44.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 17, 2024 | Ted Yednock Evp & Chief Innovation Officer | xxxxxxxxxxxxx | $6658 |
| Feb 21, 2024 | Ted Yednock Evp & Chief Innovation Officer | xxxxxxxxxxxxx | $14348 |
| Feb 21, 2024 | Jennifer Lew Evp & Cfo | xxxxxxxxxxxxx | $14339 |
| Feb 21, 2024 | Michael Overdorf Evp & Chief Business Officer | xxxxxxxxxxxxx | $10691 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $11297526 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $20306547 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,017,617 | Institution | 15.96% | 72,154,696 | |
| 7,406,024 | Insider | 6.95% | 31,401,542 | |
| 4,868,603 | Insider | 6.20% | 20,642,877 | |
| 4,544,256 | Institution | 4.26% | 19,267,645 | |
| 4,133,514 | Institution | 3.88% | 17,526,099 | |
| 3,430,160 | Institution | 3.22% | 14,543,878 | |
| 2,766,677 | Institution | 2.60% | 11,730,710 | |
| 2,629,323 | Institution | 2.47% | 11,148,330 | |
| 1,908,366 | Institution | 1.79% | 8,091,472 | |
| 1,875,649 | Institution | 1.76% | 7,952,752 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,133,514 | Institution | 3.88% | 17,526,099 | |
| 2,766,677 | Institution | 2.60% | 11,730,710 | |
| 1,875,649 | Institution | 1.76% | 7,952,752 | |
| 1,543,912 | Institution | 1.45% | 6,546,187 | |
| 1,088,067 | Institution | 1.02% | 4,613,404 | |
| 958,237 | Institution | 0.90% | 4,062,925 | |
| 805,690 | Institution | 0.76% | 3,416,126 | |
| 668,226 | Institution | 0.63% | 2,833,278 | |
| 660,001 | Institution | 0.62% | 2,798,404 | |
| 508,833 | Institution | 0.48% | 2,157,452 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,063,358 | Institution | 12.26% | 7,044,655 | |
| 3,009,244 | Institution | 2.82% | 16,219,825 | |
| 2,560,657 | Institution | 2.40% | 10,857,186 | |
| 2,435,397 | Institution | 2.28% | 11,032,348 | |
| 920,158 | Institution | 0.86% | 3,901,470 | |
| 568,313 | Institution | 0.53% | 2,409,647 | |
| 452,633 | Institution | 0.42% | 2,439,692 | |
| 418,653 | Institution | 0.39% | 1,896,498 | |
| 255,048 | Institution | 0.24% | 1,155,367 | |
| 227,918 | Institution | 0.21% | 966,372 |
FAQ
Who Owns Annexon Biosciences (ANNX)?
According to the latest TipRanks data, approximately 0.51% of the company's stock is held by institutional investors, 13.86% is held by insiders, and 44.86% is held by retail investors.
What percentage of Annexon Biosciences (ANNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.51% of Annexon Biosciences (ANNX) stock is held by institutional investors.
What percentage of Annexon Biosciences (ANNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.86% of Annexon Biosciences (ANNX) stock is held by retail investors.
Who owns the most shares of Annexon Biosciences (ANNX)?
Vanguard owns the most shares of Annexon Biosciences (ANNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.